Cited by 293SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesAnimal Virus Infections Studies

The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.

A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin

Open access

Hasan, Anwarul, Paray, Bilal Ahamad, Hussain, Arif, Qadir, Fikry Ali, Attar, Farnoosh, Aziz, Falah Mohammad, Sharifi, Majid, Derakhshankhah, Hossein, Rasti, Behnam, Mehrabi, Masoumeh, Shahpasand, Koorosh, Saboury, Ali Akbar, Falahati, Mojtaba·2021·Journal of Biomolecular Structure and Dynamics

DOI 10.1080/07391102.2020.1754293PMC PMC7189411

Open this paper in CoChat — free account

Abstract

The widespread antigenic changes lead to the emergence of a new type of coronavirus (CoV) called as severe acute respiratory syndrome (SARS)-CoV-2 that is immunologically different from the previous circulating species. Angiotensin-converting enzyme-2 (ACE-2) is one of the most important receptors on the cell membrane of the host cells (HCs) which its interaction with spike protein (SP) with a furin-cleavage site results in the SARS-CoV-2 invasion. Hence, in this review, we presented an overview on the interaction of ACE-2 and furin with SP. As several kinds of CoVs, from various genera, have at their S1/S2 binding site a preserved site, we further surveyed the role of furin cleavage site (FCS) on the life cycle of the CoV. Furthermore, we discussed that the small molecular inhibitors can limit the interaction of ACE-2 and furin with SP and can be used as potential therapeutic platforms to combat the spreading CoV epidemic. Finally, some ongoing challenges and future prospects for the development of potential drugs to promote targeting specific activities of the CoV were reviewed. In conclusion, this review may pave the way for providing useful information about different compounds involved in improving the effectiveness of CoV vaccine or drugs with minimum toxicity against human health.Communicated by Ramaswamy H. Sarma.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1080/07391102.2020.1754293

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J., & Hsueh, P.-R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105924 · Cited by 6,068
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
The reproductive number of COVID-19 is higher compared to SARS coronavirus
Liu, Y., Gayle, A. A., Wilder‐Smith, A., & Rocklöv, J. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa021 · Cited by 3,243
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Letko, M., Marzi, A., & Munster, V. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0688-y · Cited by 3,109
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Fang, L., Karakiulakis, G., & Roth, M. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30116-8 · Cited by 2,947
Structure, Function, and Evolution of Coronavirus Spike Proteins
Li, F. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-042301 · Cited by 2,740
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05985-9 · Cited by 2,684

Show all 84 references

Research works printed but not linked: 3

Kong R., 2020, arXiv Preprint arXiv:2003.00163, 1, 1 · arXiv
Letko M. C., 2020, bioRxiv, 1, 1
Xi J., 2020, medRxiv, 1, 1

Sorted by citations

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
Huang, Y., Yang, C., Xu, X.-F., Xü, W., & Liu, S. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0485-4 · Cited by 2,288
The Lancet Commission on lessons for the future from the COVID-19 pandemic
Sachs, J. D., Karim, S. S. A., Aknin, L., Allen, J., Brosbøl, K., Colombo, F., Barron, G. C., Espinosa, M. F., Gaspar, V., Gaviria, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01585-9 · Cited by 842
Emerging Pandemic Diseases: How We Got to COVID-19
Morens, D. M., & Fauci, A. S. (2020) · Cell · doi:10.1016/j.cell.2020.08.021 · Cited by 780
Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment
Boopathi, S., Poma, A. B., & Kolandaivel, P. G. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1758788 · Cited by 549
COVID-19: Drug Targets and Potential Treatments
Gil, C., Ginex, T., Maestro, I., Nozal, V., Barrado-Gil, L., Cuesta-Geijo, M. Á., Urquiza, J., Ramírez, D., Alonso, C., Campillo, N. E., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00606 · Cited by 456
Human coronaviruses OC43 and HKU1 bind to 9- O -acetylated sialic acids via a conserved receptor-binding site in spike protein domain A
Hulswit, R. J. G., Lang, Y., Bakkers, M. J. G., Li, W., Li, Z., Schouten, A., Ophorst, B., van Kuppeveld, F. J. M., Boons, G., Bosch, B., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809667116 · Cited by 384
An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study
Das, S., Sarmah, S., Lyndem, S., & Roy, A. S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1763201 · Cited by 385
Using X-ray images and deep learning for automated detection of coronavirus disease
Asnaoui, K. E., & Chawki, Y. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1767212 · Cited by 369
Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease
Joshi, R. S., Jagdale, S. S., Bansode, S. B., Shankar, S. S., Tellis, M. B., Pandya, V. K., Chugh, A., Giri, A. P., & Kulkarni, M. J. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1760137 · Cited by 359
A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2
Islam, R., Parves, M. R., Paul, A. S., Uddin, N., Rahman, M. S., Mamun, A. A., Hossain, M. N., Ali, M., & Halim, M. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1761883 · Cited by 339
Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors – an in silico docking and molecular dynamics simulation study
Ghosh, R., Chakraborty, A., Biswas, A., & Chowdhuri, S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1779818 · Cited by 305
SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective
Elfiky, A. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1761882 · Cited by 284
COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics
Yesudhas, D., Srivastava, A., & Gromiha, M. M. (2020) · Infection · doi:10.1007/s15010-020-01516-2 · Cited by 329
Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
Samuel, R. M., Majd, H., Richter, M. N., Ghazizadeh, Z., Zekavat, S. M., Navickas, A., Ramirez, J. T., Asgharian, H., Simoneau, C. R., Bonser, L. R., et al. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.11.009 · Cited by 267
Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development
Pandey, P., Rane, J. S., Chatterjee, A., Kumar, A., Khan, R., Prakash, A., & Ray, S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1796811 · Cited by 267
Stilbene-based natural compounds as promising drug candidates against COVID-19
Wahedi, H. M., Ahmad, S., & Abbasi, S. W. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1762743 · Cited by 249
Natural products may interfere with SARS-CoV-2 attachment to the host cell
Elfiky, A. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1761881 · Cited by 218
Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2
Ou, T., Mou, H., Zhang, L., Ojha, A., Choe, H., & Farzan, M. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009212 · Cited by 217
Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity
Sakaguchi, W., Kubota, N., Shimizu, T., Saruta, J., Fuchida, S., Kawata, A., Yamamoto, Y., Sugimoto, M., Yakeishi, M., & Tsukinoki, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176000 · Cited by 200
Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches
Kumar, A., Choudhir, G., Shukla, S. K., Sharma, M., Tyagi, P. K., Bhushan, A., & Rathore, M. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1772112 · Cited by 212
Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): anin silicoscreening of alkaloids and terpenoids from African medicinal plants
Gyebi, G. A., Ogunro, O. B., Adegunloye, A. P., Ogunyemi, O. M., & Afolabi, S. O. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1764868 · Cited by 199
SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development
Murgolo, N., Therien, A. G., Howell, B. J., Klein, D. J., Koeplinger, K. A., Lieberman, L. A., Adam, G. C., Flynn, J. A., McKenna, P. M., Swaminathan, G., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009225 · Cited by 204
Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach
Samad, A., Ahammad, F., Nain, Z., Alam, R., Imon, R. R., Hasan, M., & Rahman, M. S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1792347 · Cited by 191
Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking
Engin, A. B., Engin, A., & Engin, A. (2020) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2020.103411 · Cited by 189
An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets
Sinha, S. K., Shakya, A., Prasad, S. K., Singh, S., Gurav, N. S., Prasad, R. S., & Gurav, S. S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1762741 · Cited by 190
In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2
Prasanth, D., Murahari, M., Chandramohan, V., Panda, S. P., Rao, A. L., & Guntupalli, C. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1779129 · Cited by 178
Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells
Kumar, V., Dhanjal, J. K., Bhargava, P., Kaul, A., Wang, J., Zhang, H., Kaul, S. C., Wadhwa, R., & Sundar, D. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1775704 · Cited by 176
In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria
Abdelli, I., Hassani, F., Brikci, S. B., & Ghalem, S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1763199 · Cited by 173
Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2—a molecular dynamic study
Khan, M. T., Ali, A., Wang, Q., Irfan, M., Khan, A., Zeb, M. T., Zhang, Y.-J., Chinnasamy, S., & Wei, D. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1769733 · Cited by 168
Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19
Ramarao, P., Joshi, G., & Jagadeesh, G. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109721 · Cited by 160
Antiviral effects of probiotic metabolites on COVID-19
Anwar, F., Altayb, H. N., Al-Abbasi, F. A., Al‐Malki, A. L., Kamal, M. A., & Kumar, V. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1775123 · Cited by 152
Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (M pro ) of SARS-CoV-2 and inhibit its activity
Kumar, V., Dhanjal, J. K., Kaul, S. C., Wadhwa, R., & Sundar, D. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1772108 · Cited by 151
Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2
Al-Khafaji, K., AL-Duhaidahawi, D., & Taşkın‐Tok, T. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1764392 · Cited by 144
Design of multi-epitope vaccine candidate against SARS-CoV-2: ain-silicostudy
Peele, K. A., Srihansa, T., Krupanidhi, S., Ayyagari, V. S., & Venkateswarulu, T. C. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1770127 · Cited by 134
Lycopene: A Natural Arsenal in the War against Oxidative Stress and Cardiovascular Diseases
Bin-Jumah, M. N., Nadeem, M. S., Gilani, S. J., Mubeen, B., Ullah, I., Alzarea, S. I., Ghoneim, M. M., Alshehri, S., Al-Abbasi, F. A., & Kazmi, I. A. (2022) · Antioxidants · doi:10.3390/antiox11020232 · Cited by 148
Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms
Quimque, M. T. J., Notarte, K. I., Fernandez, R. A. T., Mendoza, M. A. O., Liman, R. A. D., Lim, J. A. K., Pilapil, L. A. E., Ong, J. K. H., Pastrana, A. M., Khan, A., et al. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1776639 · Cited by 131
Assessing the mechanism of barriers towards green finance and public spending in small and medium enterprises from developed countries
Chien, F., Ngo, T. Q., Hsu, C., Chau, K. Y., & Iram, R. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-14907-1 · Cited by 144
Contributions of human ACE2 and TMPRSS2 in determining host–pathogen interaction of COVID-19
Senapati, S., Banerjee, P., Bhagavatula, S., Kushwaha, P. P., & Kumar, S. (2021) · Journal of Genetics · doi:10.1007/s12041-021-01262-w · Cited by 127
Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): a simplified summary
Hendaus, M. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1767691 · Cited by 117
Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach
Chikhale, R. V., Gurav, S. S., Patil, R. B., Sinha, S. K., Prasad, S. K., Shakya, A., Shrivastava, S. K., Gurav, N. S., & Prasad, R. S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1778539 · Cited by 117
The biological activities of postbiotics in gastrointestinal disorders
Abbasi, A., Rad, A. H., Ghasempour, Z., Sabahi, S., Kafil, H. S., Hasannezhad, P., Saadat, Y. R., & Shahbazi, N. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1895061 · Cited by 114
Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (Mpro) inhibitors to unveil a hope against COVID-19
Adem, Ş., Eyüpoğlu, V., Ibrahim, I. M., Sarfraz, I., Rasul, A., Ali, M., & Elfiky, A. A. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105452 · Cited by 111
Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of some in-house molecules as papain-like protease (PLpro) inhibitors
Amin, S. A., Ghosh, K., Gayen, S., & Jha, T. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1780946 · Cited by 112
Ethnomedicines of Indian origin for combating COVID-19 infection by hampering the viral replication: using structure-based drug discovery approach
Lakshmi, S. A., Shafreen, R. B., Priya, A., & Pandian, S. K. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1778537 · Cited by 103
The Inflammasome in Times of COVID-19
Vaccari, J. C. D. R., Dietrich, W. D., Keane, R. W., & Vaccari, J. P. D. R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583373 · Cited by 104
First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations
Paniri, A., Hosseini, M. M., & Akhavan‐Niaki, H. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1767690 · Cited by 101
Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2
Khelfaoui, H., Harkati, D., & Saleh, B. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1803967 · Cited by 106
FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication
Lobo-Galo, N., Terrazas-López, M., Martı́nez-Martı́nez, A., & Díaz‐Sánchez, Á. G. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1764393 · Cited by 98
Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19
Sehailia, M., & Chemat, S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1796809 · Cited by 99
Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches
Gioia, M., Ciaccio, C., Calligari, P. A., Simone, G. D., Sbardella, D., Tundo, G. R., Fasciglione, G. F., di Masi, A., Pierro, D. D., Bocedi, A., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114225 · Cited by 100
Expression of ACE2 in airways: Implication for COVID‐19 risk and disease management in patients with chronic inflammatory respiratory diseases
Yao, Y., Wang, H., & Liu, Z. (2020) · Clinical & Experimental Allergy · doi:10.1111/cea.13746 · Cited by 93
Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects
Varahachalam, S. P., Lahooti, B., Chamaneh, M., Bagchi, S., Chhibber, T., Morris, K., Bolanos, J. F., Kim, N., & Kaushik, A. K. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s283686 · Cited by 95
Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations
Sk, M. F., Roy, R., Jonniya, N. A., Poddar, S., & Kar, P. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1768149 · Cited by 91
Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target
Arun, K. G., Sharanya, C. S., Jayanandan, A., Francis, D., & Sadasivan, C. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1779819 · Cited by 91
Structural and simulation analysis of hotspot residues interactions of SARS-CoV 2 with human ACE2 receptor
Veeramachaneni, G. K., Thunuguntla, V. B. S. C., Bobbillapati, J., & Bondili, J. S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1773318 · Cited by 93
In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19
Chikhale, R. V., Sinha, S. K., Patil, R. B., Prasad, S. K., Shakya, A., Gurav, N. S., Prasad, R. S., Dhaswadikar, S. R., Wanjari, M., & Gurav, S. S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1784289 · Cited by 86
An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
Indari, O., Jakhmola, S., Manivannan, E., & Jha, H. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.632677 · Cited by 85
Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update
Anand, U., Jakhmola, S., Indari, O., Jha, H. C., Chen, Z., Tripathi, V. S., & de la Lastra, J. M. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658519 · Cited by 84
Oral antiviral treatments for COVID-19: opportunities and challenges
Rahmah, L., Abarikwu, S. O., Arero, A. G., Essouma, M., Jibril, A. T., Fal, A., Flisiak, R., Makuku, R., Marquez, L. P., Mohamed, K., et al. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00388-7 · Cited by 88
Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus
Adeoye, A. O., Oso, B. J., Olaoye, I. F., Tijjani, H., & Adebayo, A. I. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1765876 · Cited by 82
A Global Picture: Therapeutic Perspectives for COVID-19
Chavda, V. P., Kapadia, C., Soni, S., Prajapati, R., Chauhan, S. C., Yallapu, M. M., & Apostolopoulos, V. (2022) · Immunotherapy · doi:10.2217/imt-2021-0168 · Cited by 88
Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an in silico based approach
Mahanta, S., Chowdhury, P., Gogoi, N., Goswami, N., Borah, D., Kumar, R., Chetia, D., Borah, P., Buragohain, A. K., & Gogoi, B. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1768902 · Cited by 82
Drug targets for COVID-19 therapeutics: Ongoing global efforts
Saxena, A. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-00067-w · Cited by 84
Natural compounds fromClerodendrumspp. as possible therapeutic candidates against SARS-CoV-2: Anin silicoinvestigation
Kar, P., Sharma, N. R., Singh, B., Sen, A., & Roy, A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1780947 · Cited by 84
Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2
Yadav, R., Imran, M., Dhamija, P., Chaurasia, D. K., & Handu, S. S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1796812 · Cited by 79
Potential Natural Products Against Respiratory Viruses: A Perspective to Develop Anti-COVID-19 Medicines
Omrani, M., Keshavarz, M., Ebrahimi, S. N., Mehrabi, M., McGaw, L. J., Abdalla, M. A., & Mehrbod, P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.586993 · Cited by 79
Self-citation
Structure of Furin Protease Binding to SARS-CoV-2 Spike Glycoprotein and Implications for Potential Targets and Virulence
Vankadari, N. (2020) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.0c01698 · Cited by 78
Identification of potential anti-TMPRSS2 natural products through homology modelling, virtual screening and molecular dynamics simulation studies
Chikhale, R. V., Gupta, V. K., Eldesoky, G. E., Wabaidur, S. M., Patil, S. A., & Islam, M. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1798813 · Cited by 78
Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease – in silico approach
Naik, V. R., Munikumar, M., Ungarala, R., Medithi, S., Goudar, G., Naresh, P., Kumar, B. N., & Rajkumar, H. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1781694 · Cited by 76
In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2
Beura, S., & Chetti, P. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1772111 · Cited by 73
Structure of the SARS-CoV-2 Nsp1/5′-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and Virulence
Vankadari, N., Jeyasankar, N. N., & Lopes, W. J. (2020) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.0c02818 · Cited by 73
Rapid Antibody-Based COVID-19 Mass Surveillance: Relevance, Challenges, and Prospects in a Pandemic and Post-Pandemic World
Augustine, R., Das, S., Hasan, A., Abhilash, S., Salam, S. A., Augustine, P., Dalvi, Y. B., Varghese, R., Primavera, R., Yassine, H. M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103372 · Cited by 71
Self-citation
Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza
Saadat, Y. R., Khatibi, S. M. H., Vahed, S. Z., & Ardalan, M. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.725528 · Cited by 76
Human animal interface of SARS-CoV-2 (COVID-19) transmission: a critical appraisal of scientific evidence
Singla, R., Mishra, A., Joshi, R., Jha, S., Sharma, A. R., Upadhyay, S., Sarma, P., Prakash, A., & Medhi, B. (2020) · Veterinary Research Communications · doi:10.1007/s11259-020-09781-0 · Cited by 67
Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent
Basit, A., Ali, T., & Rehman, S. U. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1768150 · Cited by 67
In silico investigation of spice molecules as potent inhibitor of SARS-CoV-2
Rout, J., Swain, B. C., & Tripathy, U. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1819879 · Cited by 66
Covalent Organic Frameworks (COFs) as Multi-Target Multifunctional Frameworks
Bukhari, S. N. A., Ahmed, N., Amjad, M. W., Hussain, M. A., Elsherif, M. A., Ejaz, H., & Alotaibi, N. H. (2023) · Polymers · doi:10.3390/polym15020267 · Cited by 64
TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection
Metzdorf, K., Jacobsen, H., Greweling‐Pils, M. C., Hoffmann, M., Lüddecke, T., Miller, F., Melcher, L., Kempf, A. M., Nehlmeier, I., Bruder, D., et al. (2023) · Viruses · doi:10.3390/v15020271 · Cited by 66
The Cellular basis of loss of smell in 2019-nCoV-infected individuals
Gupta, K., Mohanty, S. K., Mittal, A., Kalra, S., Kumar, S., Mishra, T., Ahuja, J., Sengupta, D., & Ahuja, G. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa168 · Cited by 62
Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach
Mohammad, T., Choudhury, A., Habib, I., Asrani, P., Mathur, Y., Umair, M., Anjum, F., Shafie, A., Yadav, D. K., & Hassan, M. I. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.765039 · Cited by 61
Anti-Infective, Anti-Inflammatory, and Immunomodulatory Properties of Breast Milk Factors for the Protection of Infants in the Pandemic From COVID-19
Quitadamo, P. A., Comegna, L., & Cristalli, P. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2020.589736 · Cited by 60
Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CL pro )
Koulgi, S., Jani, V., N, M. U. V., Sonavane, U., Nath, A. K., Darbari, H., & Joshi, R. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1792344 · Cited by 60
A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19
Logette, E., Lorin, C., Favreau, C., Oshurko, E., Coggan, J. S., Casalegno, F., Sy, M. F., Monney, C., Bertschy, M., Delattre, É., et al. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.695139 · Cited by 58
Alantolactone: A Natural Plant Extract as a Potential Therapeutic Agent for Cancer
Cai, Y., Gao, K., Peng, B., Xu, Z., Peng, J., Li, J., Chen, X., Zeng, S., Hu, K., & Yan, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.781033 · Cited by 55
Immunoinformatics design of a structural proteins driven multi-epitope candidate vaccine against different SARS-CoV-2 variants based on fynomer
Sarvmeili, J., Kohnehrouz, B. B., Gholizadeh, A., Shanehbandi, D., & Ofoghi, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-61025-2 · Cited by 54
Virtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2
Yadav, R., Imran, M., Dhamija, P., Suchal, K., & Handu, S. S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1778536 · Cited by 53
The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID‐19 Patients
Soltani, S., Zakeri, A., Zandi, M., Kesheh, M. M., Tabibzadeh, A., Dastranj, M., Faramarzi, S., Didehdar, M., Hafezi, H., Hosseini, P., et al. (2021) · BioMed Research International · doi:10.1155/2021/6670798 · Cited by 53
Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation
Augustine, R., Abhilash, S., Nayeem, A., Salam, S. A., Augustine, P., Dan, P., Maureira, P., Mraiche, F., Gentile, C., Hansbro, P. M., et al. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109738 · Cited by 55
Self-citation
Genome sequencing and analysis of an emergent SARS-CoV-2 variant characterized by multiple spike protein mutations detected from the Central Visayas Region of the Philippines
Tablizo, F. A., Kim, K. M., Lapid, C. M., Castro, M. J. R., Yangzon, M. S. L., Maralit, B. A., Ayes, M. E. C., Cutiongco-de la Paz, E. M., De Guzman, A. R., Yap, J. M. C., et al. (2021) · doi:10.1101/2021.03.03.21252812 · Cited by 46
Implications of testicular ACE2 and the renin–angiotensin system for SARS-CoV-2 on testis function
Edenfield, R. C., & Easley, C. A. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00542-5 · Cited by 55
Development of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase
Babadaei, M. M. N., Hasan, A., Vahdani, Y., Bloukh, S. H., Sharifi, M., Kachooei, E., Haghighat, S., & Falahati, M. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1767210 · Cited by 50
Self-citation
Fragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main protease
Choudhury, C. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1771424 · Cited by 51
Coronavirus (SARS-CoV-2) Pandemic: Future Challenges for Dental Practitioners
Bordea, I. R., Xhajanka, E., Candrea, S., Bran, S., Onisor, F. G., Inchingolo, A. D., Malcangi, G., Pham, V. H., Inchingolo, A. M., Scarano, A., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8111704 · Cited by 50
A molecular docking study of SARS-CoV-2 main protease against phytochemicals of Boerhavia diffusa Linn. for novel COVID-19 drug discovery
Ulhas, R. S., & Praveen, N. (2021) · VirusDisease · doi:10.1007/s13337-021-00683-6 · Cited by 50
Impact of Expressing Cells on Glycosylation and Glycan of the SARS-CoV-2 Spike Glycoprotein
Wang, Y., Wu, Z., Hu, W., Hao, P., & Yang, S. (2021) · ACS Omega · doi:10.1021/acsomega.1c01785 · Cited by 50
Cyanobacterial metabolites as promising drug leads against the M pro and PL pro of SARS-CoV-2: an in silico analysis
Naidoo, D., Roy, A., Kar, P., Mutanda, T., & Anandraj, A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1794972 · Cited by 52
The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2
Shagufta, & Ahmad, I. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113157 · Cited by 47
New progresses on cell surface protein HSPA5/BiP/GRP78 in cancers and COVID-19
Li, T., Fu, J., Cheng, J., Elfiky, A. A., Wei, C., & Fu, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1166680 · Cited by 48
SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention
Inchingolo, A. D., Inchingolo, A. M., Bordea, I. R., Malcangi, G., Xhajanka, E., Scarano, A., Lorusso, F., Farronato, M., Tartaglia, G. M., Isacco, C. G., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9030525 · Cited by 49
Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp)
Bibi, S., Hasan, M. M., Wang, Y., Papadakos, S. P., & Yu, H. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210820114025 · Cited by 50

Authors: Hasan, A., Paray, B. A., Hussain, A., Qadir, F. A., Attar, F., Aziz, F. M., Sharifi, M., Derakhshankhah, H., Rasti, B., Mehrabi, M., Shahpasand, K., Saboury, A. A., & Falahati, M.
Affiliations: Qatar University (QA)
King Saud University (SA)
Manipal Academy of Higher Education, Dubai (AE)
Salahaddin University-Erbil (IQ)
Standard Research Institute (IR)
Islamic Azad University, Tehran (IR)
Kermanshah University of Medical Sciences (IR)
Islamic Azad University, Lahijan Branch (IR)
Royan Institute (IR)
University of Tehran (IR)
Corresponding author: Hasan, Anwarul
Falahati, Mojtaba
ORCID: Hasan, Anwarul
Hussain, Arif
Qadir, Fikry Ali
Sharifi, Majid
Derakhshankhah, Hossein
Rasti, Behnam
Shahpasand, Koorosh
Saboury, Ali Akbar
Falahati, Mojtaba
Venue: Journal of Biomolecular Structure and Dynamics
Publisher: Informa UK Limited
Published: 2020-04-22
Volume: 39
Issue: 8
Pages: 3025-3033
ISSN: 0739-1102 (ISSN-L)
1538-0254
DOI: 10.1080/07391102.2020.1754293
PMC: PMC7189411
OpenAlex: W3015385976
Cited by: 293
References: 84
Citations by year: 2026: 3 · 2025: 9 · 2024: 18 · 2023: 24 · 2022: 40 · 2021: 83 · 2020: 115
FWCI: 3.09
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Journal of Biomolecular Structure and Dynamics (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Qatar University QSpace (Qatar University) (submittedVersion)
Funders: Qatar Foundation (GCC-2017-005, NPRP10-120-170-211)
Fonds National de la Recherche Luxembourg
Qatar University (GCC-2017-005)
Qatar National Research Fund (NPRP10, NPRP10-120-170-211, GCC-2017-005)
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
Keywords: SARS-CoV-2, spike protein, furin cleavage site, angiotensin-converting enzyme 2, viral entry, host cell receptors, S1/S2 cleavage, small molecule inhibitors, antiviral drug discovery, coronavirus vaccines
MeSH terms: Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Angiotensins, Humans, Furin, Spike Glycoprotein, Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks